JP2022510387A5 - - Google Patents
Info
- Publication number
- JP2022510387A5 JP2022510387A5 JP2021531558A JP2021531558A JP2022510387A5 JP 2022510387 A5 JP2022510387 A5 JP 2022510387A5 JP 2021531558 A JP2021531558 A JP 2021531558A JP 2021531558 A JP2021531558 A JP 2021531558A JP 2022510387 A5 JP2022510387 A5 JP 2022510387A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- epitope
- product according
- pharmaceutical product
- population
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024224774A JP2025063054A (ja) | 2018-12-03 | 2024-12-20 | ガンマデルタｔ細胞集団の選択的生体内増殖方法及びその組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774817P | 2018-12-03 | 2018-12-03 | |
| US62/774,817 | 2018-12-03 | ||
| PCT/US2019/064319 WO2020117862A1 (en) | 2018-12-03 | 2019-12-03 | Methods for selective in vivo expansion of gamma delta t-cell populations and compositions thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024224774A Division JP2025063054A (ja) | 2018-12-03 | 2024-12-20 | ガンマデルタｔ細胞集団の選択的生体内増殖方法及びその組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022510387A JP2022510387A (ja) | 2022-01-26 |
| JP2022510387A5 true JP2022510387A5 (enExample) | 2022-12-14 |
Family
ID=69005987
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531558A Pending JP2022510387A (ja) | 2018-12-03 | 2019-12-03 | ガンマデルタｔ細胞集団の選択的生体内増殖方法及びその組成物 |
| JP2024224774A Pending JP2025063054A (ja) | 2018-12-03 | 2024-12-20 | ガンマデルタｔ細胞集団の選択的生体内増殖方法及びその組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024224774A Pending JP2025063054A (ja) | 2018-12-03 | 2024-12-20 | ガンマデルタｔ細胞集団の選択的生体内増殖方法及びその組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220218747A1 (enExample) |
| EP (1) | EP3890757A1 (enExample) |
| JP (2) | JP2022510387A (enExample) |
| KR (1) | KR20210099615A (enExample) |
| CN (1) | CN113518624A (enExample) |
| AU (1) | AU2019394877A1 (enExample) |
| BR (1) | BR112021010804A2 (enExample) |
| CA (1) | CA3126896A1 (enExample) |
| IL (1) | IL283614B1 (enExample) |
| MX (1) | MX2021006503A (enExample) |
| SG (1) | SG11202105860QA (enExample) |
| WO (1) | WO2020117862A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2022006547A (es) * | 2019-12-03 | 2022-08-19 | Adicet Bio Inc | Métodos para la expansión de poblaciones de células t gamma delta con agentes multivalentes y composiciones de estas. |
| WO2022109477A1 (en) * | 2020-11-23 | 2022-05-27 | University Of Florida Research Foundation, Incorporated | Use of insulin-like growth factors with gamma-chain cytokines to induce homeostatic proliferation of lymphocytes |
| CN115746131B (zh) * | 2022-08-01 | 2025-09-30 | 杭州旭科生物技术有限公司 | 抗天然类风湿因子rf的单克隆抗体及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
| US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP0633943A4 (en) | 1992-04-03 | 1997-05-02 | Alexander T Young | GENTHERAPY USING TARGETED VIRAL VECTORS. |
| WO2003087341A2 (en) | 2002-01-23 | 2003-10-23 | The University Of Utah Research Foundation | Targeted chromosomal mutagenesis using zinc finger nucleases |
| US7985739B2 (en) | 2003-06-04 | 2011-07-26 | The Board Of Trustees Of The Leland Stanford Junior University | Enhanced sleeping beauty transposon system and methods for using the same |
| CA2569509C (en) * | 2004-06-03 | 2014-08-12 | Novimmune S.A. | Anti-cd3 antibodies and methods of use thereof |
| MX336846B (es) | 2010-01-22 | 2016-02-03 | Sangamo Biosciences Inc | Alteracion genomica dirigida. |
| MX2013011363A (es) | 2011-04-01 | 2014-04-25 | Sloan Kettering Inst Cancer | Anticuerpos para peptidos citosolicos. |
| EP2684600A1 (en) | 2012-07-10 | 2014-01-15 | Laboratoires Meiners Sarl | Core-shell capsules and methods for encapsulation of reactive ingredients by diffusional exchange through spherical capsule membranes |
| JP2016501013A (ja) * | 2012-11-08 | 2016-01-18 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | γδＴ細胞の無ＩＬ−２増殖を誘導するための方法 |
| WO2014134412A1 (en) | 2013-03-01 | 2014-09-04 | Regents Of The University Of Minnesota | Talen-based gene correction |
| CN104651308A (zh) * | 2013-11-22 | 2015-05-27 | 深圳先进技术研究院 | 一种用磷酸盐扩增γδT细胞的方法及其应用 |
| IL297773B2 (en) * | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| HK1255161A1 (zh) | 2015-07-15 | 2019-08-09 | Juno Therapeutics, Inc. | 用於过继性细胞治疗的工程细胞 |
| US11299708B2 (en) * | 2016-05-12 | 2022-04-12 | Adicet Bio, Inc. | Methods for selective expansion of γδ T-cell populations and compositions thereof |
| MX2020005005A (es) | 2017-11-15 | 2020-08-27 | Adicet Bio Inc | Métodos para la expansión selectiva de poblaciones de células t gamma delta delta 3 y composiciones de estas. |
-
2019
- 2019-12-03 SG SG11202105860QA patent/SG11202105860QA/en unknown
- 2019-12-03 KR KR1020217020436A patent/KR20210099615A/ko not_active Ceased
- 2019-12-03 EP EP19828054.7A patent/EP3890757A1/en active Pending
- 2019-12-03 JP JP2021531558A patent/JP2022510387A/ja active Pending
- 2019-12-03 AU AU2019394877A patent/AU2019394877A1/en active Pending
- 2019-12-03 BR BR112021010804A patent/BR112021010804A2/pt unknown
- 2019-12-03 CA CA3126896A patent/CA3126896A1/en active Pending
- 2019-12-03 US US17/298,903 patent/US20220218747A1/en active Pending
- 2019-12-03 CN CN201980087911.3A patent/CN113518624A/zh active Pending
- 2019-12-03 WO PCT/US2019/064319 patent/WO2020117862A1/en not_active Ceased
- 2019-12-03 MX MX2021006503A patent/MX2021006503A/es unknown
-
2021
- 2021-06-01 IL IL283614A patent/IL283614B1/en unknown
-
2024
- 2024-12-20 JP JP2024224774A patent/JP2025063054A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7451627B2 (ja) | キメラ受容体及びその使用方法 | |
| Santos et al. | Advances and challenges in therapeutic monoclonal antibodies drug development | |
| KR102591930B1 (ko) | Bcma 결합 분자 및 그의 사용 방법 | |
| KR102389096B1 (ko) | Flt3에 대한 키메라 수용체 및 이의 사용 방법 | |
| JP2025170245A (ja) | γδＴ細胞集団の選択的増殖方法及びその組成物 | |
| ES2240962T3 (es) | Metodo para estimular selectivamente la proliferacion de celulas t. | |
| JP4736037B2 (ja) | ヒトｇｍ−ｃｓｆに結合するヒトのモノクローナル抗体並びにその抗原結合部分 | |
| JP2021532829A5 (enExample) | ||
| US20060188493A1 (en) | Use of an active substance that binds to cd28 for producing a pharmaceutical composition | |
| JP2022510387A5 (enExample) | ||
| JP2006508689A (ja) | 選択的ＩＦＮ−γ経路インヒビターとしてのヒト抗ＩＦＮ−γ中和抗体 | |
| CN113795506A (zh) | 用于治疗CD1a阳性癌症的CAR T细胞 | |
| JP2023504185A (ja) | γδＴ細胞集団を多価薬剤で増殖させるための方法及びその組成物 | |
| JP2026016543A (ja) | 改変された制御性ｔ細胞 | |
| WO2001087058A1 (en) | Chimeric mouse having immunity constructed by using human cd34-positive cells and use thereof | |
| JP2025063054A (ja) | ガンマデルタｔ細胞集団の選択的生体内増殖方法及びその組成物 | |
| US12509525B2 (en) | CAR T-cells against BCMA for the treatment of multiple myeloma | |
| CN115843255A (zh) | 用于治疗b细胞型急性淋巴细胞白血病（b-all）的cd22靶向部分 | |
| US20250145693A1 (en) | Herv-k antibody, cell, vaccine, and drug therapeutics | |
| JPWO2019245037A1 (ja) | 免疫寛容を誘導する抗体、誘導されたリンパ球、また誘導されたリンパ球を用いる細胞治療剤治療法 | |
| WO2015075710A1 (en) | Compositions comprising anti-ceacam1 antibodies, lymphocyte activating agents and activated lymphocytes for cancer therapy | |
| US20250152710A1 (en) | Modified primary immune cells for induction or enhancement of immunotherapy | |
| CN121057748A (zh) | 用于治疗ccr9阳性癌症的ccr9靶向部分 | |
| US20240368259A1 (en) | Antibodies against lefty proteins | |
| TW202440623A (zh) | 靶向密連蛋白１８﹒２之嵌合抗原受體及結合劑以及其用途 |